Description

Product Description

Melanotan II (MT-2) is a synthetic melanocortin peptide widely used in in vitro mechanistic research to investigate melanocortin receptor signaling, peptide-receptor interactions, and downstream intracellular pathways. Unlike Melanotan I, MT-II incorporates structural modifications that confer enhanced receptor affinity, broader subtype selectivity, and improved stability, making it a versatile tool for detailed mechanistic studies in controlled laboratory environments.

Produced via solid-phase peptide synthesis (SPPS) under strict factory-controlled conditions, MT-2 achieves ≥98% purity, with each batch rigorously verified using HPLC and mass spectrometry. These measures ensure reproducible experimental outcomes and high-quality data for laboratories, contract research organizations, and international B2B buyers requiring reliable peptide sources. The combination of purity, analytical verification, and standardized production guarantees batch-to-batch consistency, which is critical for mechanistic and multi-platform studies.

Melanotan II is particularly suitable for structure–activity relationship (SAR) research, enabling systematic evaluation of peptide analogs and amino acid modifications on receptor engagement, intracellular signaling, and pathway bias. Its solubility in standard laboratory buffers and chemical stability under recommended storage conditions facilitate integration into recombinant receptor systems, engineered cell lines, and cell-free biochemical assays. Researchers can use MT-II to investigate receptor selectivity, signal transduction kinetics, second messenger dynamics, and ligand-biased pathway activation.

Beyond traditional wet-lab experimentation, MT-2 data can be incorporated into computational modeling, molecular docking, and multi-omic workflows, bridging in vitro findings with predictive receptor-ligand interaction simulations, systems biology analyses, and mechanistic network mapping. This integration enhances the reliability and reproducibility of experimental outcomes and supports hypothesis-driven experimental design.

Overall, Melanotan II provides a robust, research-grade molecular probe for studying melanocortin receptor biology, intracellular signaling pathways, and peptide-mediated molecular mechanisms. Its combination of high purity, standardized production, and analytical verification ensures it is an ideal choice for laboratories, international B2B procurement, and long-term mechanistic research programs.

Product Specifications

Melanotan II Notes:

• Designed exclusively for in vitro research and mechanistic studies.

• Factory-direct production ensures consistent quality, traceability, and reproducibility for long-term research projects.

• Analytical documentation supports B2B trust, regulatory compliance, and international procurement.

• Bulk and wholesale options are available to support high-throughput experimental workflows.

• All specifications are verified to maintain Melanotan II integrity and activity across multiple research platforms.

Mechanism of Action

Melanotan II (MT-2) functions as a high-affinity synthetic agonist for melanocortin receptors, particularly MC1R, MC3R, MC4R, and MC5R, enabling precise in vitro investigation of receptor-mediated signaling pathways. Structural modifications of MT-II, including amino acid substitutions and cyclization, confer enhanced receptor binding potency, improved stability, and subtype selectivity, providing researchers with a versatile tool to dissect receptor-ligand interactions and intracellular signaling dynamics under controlled experimental conditions.

Upon receptor binding, Melanotan II induces conformational changes in G protein-coupled receptors (GPCRs), activating the Gαs subunit and stimulating adenylyl cyclase, which elevates intracellular cAMP levels. This second messenger regulates downstream effectors, including protein kinase A (PKA), transcription factors, and other intracellular signaling proteins, making Melanotan II an ideal tool for studying signal amplification, receptor desensitization, and biased signaling. The peptide also facilitates examination of cross-talk between melanocortin receptors and other GPCRs, as well as interactions with phospholipase C, intracellular calcium mobilization, and MAP kinase pathways, providing a comprehensive mechanistic perspective.

MT-II’s receptor engagement can be monitored using quantitative receptor pharmacology approaches, such as dose-response profiling, receptor occupancy assays, and kinetic measurements, enabling precise mapping of signaling dynamics. Its chemical stability and well-characterized pharmacophore ensure reproducibility across multiple assay platforms and laboratories. Researchers often integrate MT-2 with computational modeling, molecular docking, and structure–activity relationship (SAR) analyses, which helps predict receptor-ligand interactions, optimize experimental conditions, and validate mechanistic hypotheses.

Moreover, Melanotan II is widely applied in multi-platform experimental workflows, including recombinant receptor-expressing cell lines, engineered mammalian systems, and cell-free biochemical assays. Its high purity and standardized production support B2B procurement and international research programs, ensuring that each batch yields consistent mechanistic insights. By combining MT-II with advanced imaging, reporter assays, and multi-omic techniques, laboratories can dissect receptor-specific signaling pathways, evaluate pathway bias, and integrate findings into broader mechanistic networks.

Overall, Melanotan II serves as a research-grade molecular probe for detailed investigation of melanocortin receptor biology, intracellular signal transduction, and peptide-receptor interactions, providing a robust, reliable, and mechanistically informative platform for advanced in vitro research and integrative computational studies.

Applications

Melanotan II (MT-2) serves as a research-grade synthetic peptide for in vitro investigations of melanocortin receptor biology, intracellular signaling, and peptide-receptor dynamics. Its defined structure, high purity, and reproducible activity make it a versatile tool for a variety of experimental applications in mechanistic studies and molecular pharmacology.

Receptor Binding and Selectivity Studies: MT-II is widely employed to assess ligand-receptor interactions across multiple melanocortin receptor subtypes (MC1R, MC3R, MC4R, MC5R). These assays enable researchers to quantify binding affinity, evaluate receptor selectivity, and examine conformational changes in GPCRs, providing insights into receptor-ligand kinetics and signaling efficiency.

Signal Transduction and Second Messenger Analysis: MT-II facilitates the investigation of cAMP-mediated pathways, PKA activation, intracellular calcium flux, and MAP kinase signaling. Its consistent receptor activation profile allows for precise monitoring of downstream effectors, receptor desensitization, and biased signaling, supporting high-resolution mechanistic exploration.

Structure–Activity Relationship (SAR) Research: As a well-characterized reference peptide, MT-2 enables systematic comparison of peptide analogs or sequence modifications. Researchers can explore how specific amino acid substitutions, cyclization, or chemical modifications influence receptor engagement, intracellular signaling potency, and pathway selectivity.

Mechanistic Pathway Mapping and Network Analysis: MT-II is suitable for investigating cross-talk between melanocortin receptors and other GPCRs, integration with transcriptional networks, and downstream signaling cascades. Multi-assay designs, including recombinant receptor models, engineered cell lines, and cell-free platforms, support detailed pathway elucidation and mechanistic validation.

Integration with Computational and Multi-Omic Approaches: Data generated from MT-II assays can be incorporated into molecular docking, receptor-ligand interaction simulations, systems biology modeling, and transcriptomic or proteomic analyses, bridging in vitro findings with predictive and multi-omic research. This integration enhances mechanistic understanding and supports rational experimental design.

Overall, MT-2 provides a robust, reproducible, and versatile research platform for laboratories, contract research organizations, and international B2B buyers, enabling comprehensive investigation of melanocortin receptor signaling, intracellular pathways, and peptide-mediated molecular mechanisms in strictly controlled in vitro environments.

Research Models

Melanotan II (MT-2) is designed for use in controlled in vitro experimental models, enabling detailed exploration of melanocortin receptor signaling, peptide–receptor interactions, and intracellular pathway dynamics. Its high purity and well-characterized structure make it suitable for a variety of research systems that require reproducibility and mechanistic precision.

Recombinant Receptor Systems: Melanotan II can be applied to cell lines engineered to express specific melanocortin receptor subtypes (MC1R, MC3R, MC4R, MC5R). These systems allow precise investigation of receptor-ligand interactions, binding kinetics, and downstream cAMP-mediated signaling, providing insights into receptor selectivity and activation profiles.

Engineered Cell Lines: MT-2 is compatible with mammalian or other eukaryotic cell lines modified for in vitro signaling studies. Researchers can use these models to examine signal transduction, second messenger dynamics, and pathway-specific responses under controlled conditions, minimizing confounding biological variability.

Cell-Free and Biochemical Assays: For mechanistic studies requiring receptor-independent analysis, MT-2 can be integrated into cell-free binding or enzymatic assays, allowing investigation of peptide stability, receptor affinity, and molecular interactions without the influence of cellular complexity.

Peptide–Receptor Interaction and SAR Models: MT-II serves as a reference compound for structure–activity relationship (SAR) analyses in various model systems. By comparing MT-II with analogs or modified peptides, researchers can assess how sequence or conformational changes affect receptor engagement and signaling efficiency.

Multi-Platform Integration: Data obtained from Melanotan II studies can be cross-validated across multiple in vitro systems and integrated with computational modeling, network analysis, and multi-omic workflows, enhancing mechanistic insights and supporting predictive experimental design.

Overall, MT-II provides a versatile, reproducible, and reliable research model platform, suitable for laboratories, contract research organizations, and B2B buyers conducting advanced in vitro investigations of melanocortin receptor biology and intracellular signaling pathways.

Experimental Design Considerations

When designing experiments with Melanotan II (MT-2), meticulous planning is essential to ensure reproducibility, mechanistic clarity, and data integrity. Researchers should begin by using high-purity, analytically verified peptide batches, stored under low-temperature and light-protected conditions to preserve structural stability. Reconstitution in compatible laboratory solvents should be optimized for solubility and stability, avoiding repeated freeze-thaw cycles.

Experimental parameters such as peptide concentration, incubation time, and buffer composition must be tailored to specific receptor assays or signal transduction studies. Pilot studies are recommended to determine optimal working ranges for receptor binding, second messenger quantification, or pathway activation. Standardization of receptor expression systems, assay conditions, and technical replicates is crucial to minimize variability.

Incorporating appropriate positive and negative controls enables differentiation of specific MT-II-mediated effects from background signals. Analytical verification of peptide integrity during experiments, using HPLC or mass spectrometry, supports reproducible results and mechanistic interpretation. Data should be thoroughly documented, including batch number, preparation details, and assay conditions, to maintain traceability and compliance with laboratory standards.

Cross-validation across multiple in vitro platforms, such as recombinant receptor systems, engineered cell lines, or cell-free assays, strengthens mechanistic insights. MT-II data can also be integrated with computational modeling, structure–activity relationship (SAR) analyses, and multi-omic workflows, providing a robust framework for predictive experimental design and downstream mechanistic studies.

Laboratory Safety & Handling Guidelines

Melanotan II (MT-2) is intended solely for in vitro mechanistic research. All handling must adhere to institutional safety protocols to maintain material integrity and ensure laboratory safety.

Personal Protective Equipment (PPE): Gloves, lab coat, and eye protection are required when handling powder or reconstituted solutions. Work surfaces should be clean and dedicated for peptide use to prevent contamination.

Storage and Stability: Melanotan II should be stored at low temperature, protected from light and moisture. Reconstituted solutions should be prepared fresh and avoid repeated freeze-thaw cycles to preserve activity.

Labeling and Traceability: All containers should be labeled with batch number, preparation date, and concentration. Documentation supports reproducibility, regulatory compliance, and B2B trust.

Waste Disposal: Peptide waste should be disposed of following local chemical safety regulations. Analytical verification of peptide integrity before long-term experiments is recommended to ensure reliable results.

By following these guidelines, laboratories can maintain Melanotan II stability, ensure safe handling, and achieve reproducible outcomes, reinforcing its reliability as a high-purity, factory-manufactured peptide for international B2B research programs.

Integration with Multi-Omic & Computational Studies

Melanotan II (MT-2) provides a versatile platform for integration with multi-omic and computational research, enabling comprehensive analysis of melanocortin receptor signaling and downstream intracellular pathways. Data generated from in vitro MT-II assays can be combined with transcriptomic, proteomic, and metabolomic analyses to construct detailed molecular networks and identify pathway crosstalk, regulatory nodes, and signaling dynamics. Such integration allows researchers to connect receptor-ligand interactions with broader cellular responses, providing mechanistic insights that extend beyond traditional single-assay experiments.

Melanotan II is highly suitable for use in computational modeling approaches, including molecular docking, receptor-ligand interaction simulations, and quantitative structure-activity relationship (QSAR) analyses. By leveraging experimentally derived binding affinities, activation kinetics, and receptor selectivity data, computational models can predict ligand potency, receptor engagement dynamics, and downstream pathway activation under various experimental conditions. This predictive capability enhances experimental design, reduces assay redundancy, and supports hypothesis-driven mechanistic studies.

The peptide’s chemical stability and well-characterized structure ensure reliable data across multiple experimental batches, which is critical when integrating results with systems biology simulations, network modeling, and multi-omic datasets. Researchers can use MT-II to explore cross-talk between melanocortin receptors and other GPCRs, map downstream signaling cascades, and quantify second messenger dynamics in a reproducible manner. Such datasets can then be analyzed using bioinformatic pipelines, enabling comprehensive mechanistic interpretation and facilitating translational insights in receptor pharmacology and peptide biology.

Additionally, Melanotan II supports high-throughput experimental workflows where multi-omic data can be generated across various cell lines, recombinant receptor systems, or cell-free assays. Integration of these datasets with computational predictions enhances the understanding of ligand-biased signaling, receptor subtype specificity, and pathway modulation, providing a robust foundation for advanced mechanistic research. The combination of high-purity, factory-manufactured MT-II with multi-omic and computational approaches ensures data reliability, reproducibility, and confidence for B2B buyers and research institutions conducting complex in vitro studies.

In summary, Melanotan II serves as a powerful molecular tool for bridging experimental in vitro data with computational and multi-omic analyses, offering researchers a comprehensive, reproducible, and mechanistically informative platform for advanced studies of melanocortin receptor biology and intracellular signaling networks.

Keywords

Melanotan II peptide, MT-2 high purity, Melanotan II factory manufactured, MT-2 wholesale supply, Melanotan II China exporter, melanocortin receptor peptide, research-grade MT-2, bulk MT-II supplier, in vitro peptide research

Shipping Guarantee

Secure, research-grade packaging ensures Melanotan II integrity and stability during international transit. All shipments are carefully prepared to prevent moisture, light exposure, and mechanical damage. Temperature-controlled logistics are available for long-distance or sensitive shipments, maintaining peptide quality. Packages are tracked and monitored to ensure timely delivery. Laboratories receive Melanotan II ready for immediate in vitro experimental use without compromise to purity or functionality.

Trade Assurance

Factory-direct manufacturing provides full batch traceability and rigorous analytical documentation for MT-II. Certificates of Analysis (COA) are included with each lot to ensure quality verification. Bulk and wholesale procurement options support long-term research programs and multi-assay workflows. Standardized production practices minimize variability between batches. These measures enhance confidence for B2B buyers and international research institutions seeking reliable peptide sources.

Payment Support

Multiple secure payment methods are available to facilitate global transactions. Credit card payments are accepted for convenience and rapid processing. T/T (Telegraphic Transfer) is supported for bulk or institutional orders. Encrypted cryptocurrency payment options are also available for additional security. Flexible payment solutions ensure smooth, reliable procurement for international B2B buyers.

Disclaimer

Melanotan II is supplied exclusively for laboratory research and in vitro experimental use. It is not intended for clinical, diagnostic, or therapeutic applications. Use is strictly limited to controlled laboratory environments in accordance with institutional safety protocols. Researchers must follow proper handling, storage, and disposal procedures. This disclaimer reinforces that MT-2 is a mechanistic and molecular research tool only, not for human or veterinary application.

References

• PubChem – Melanotan II (MT-2)
  Comprehensive chemical profile including molecular structure, synonyms, biological targets, and receptor data for Melanotan II. Tocris Bioscience

• Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists
  Study demonstrating how MT‑II induces prolonged cAMP signaling through melanocortin‑4 receptor (MC4R) in cell models, illustrating mechanistic differences versus endogenous ligands. PubMed

• Ligands for Melanocortin Receptors: Beyond Melanocyte Responses (PMC review)
  Open‑access review covering melanocortin receptor ligands (including MT‑II) and their signaling actions via multiple melanocortin receptors in neural and cellular systems. PMC

• MedChemExpress – Melanotan II (MT-2) Technical Datasheet
  Technical peptide datasheet summarizing MT‑II as a high‑affinity melanocortin receptor agonist, relevant for receptor binding and signaling assays in vitro. MedChemExpress

• The Melanocortin System: A Promising Target for Drug Development (MDPI review)
  Review discussing melanocortin receptor agonists (including MT‑II) and their interaction profiles with multiple receptor subtypes, supporting mechanistic receptor research contexts. MDPI

• Melanocortin 4 Receptor (MC4R) – Ligands and Mechanism (MC4R overview)
  Detailed database entry listing MT‑II among known melanocortin receptor agonists, useful for understanding receptor subtype profiling in mechanistic studies. Wikipedia